Pharma stocks bleed after Trump announces upto 200% tariff on generic drugs
Pharmaceutical stocks came under pressure on Wednesday after US President Donald Trump unveiled a phased tariff plan for imported generic medicines, raising concerns over the long-term outlook for one of the industry's biggest export markets.
Pharmaceutical stocks came under pressure on Wednesday after US President Donald Trump unveiled a phased tariff plan for imported generic medicines, raising concerns over the long-term outlook for one of the industry's biggest export markets.
What's Your Reaction?
